Literature DB >> 16204782

Quality of life during one-year observation of patients with idiopathic pulmonary fibrosis awaiting lung transplantation.

D Jastrzebski1, J Kozielski, A Banaś, T Cebula, A Gumola, D Ziora, A Krzywiecki.   

Abstract

The aim of the study was to evaluate the quality of life and its changes in patients with idiopathic pulmonary fibrosis (IPF), waiting for lung transplantation. Sixteen IPF patients, who qualified for lung transplantation, and 14 chronic obstructive pulmonary disease (COPD) patients on long term oxygen therapy, taken as a reference group, were assessed. The quality of life was estimated twice, using an SF-36-questionnaire, at the time of qualification for lung transplantation and 12 months later. The IPF and reference patients had similarly profound disturbances in lung function and arterial blood gas content. The IPF patients had a statistically greater score in their physical functioning (PF; 45 vs. 18), the role of limitations due to physical problems (RP; 43 vs. 11), social functioning (SF; 58 vs. 30), and the role of emotional limitations in everyday life (RE; 65 vs. 12) than the reference ones. After a year's observation, there were no differences in SF-36 questionnaire results, except for the role of limitations due to physical problems (RP). A correlation was noted between spirometry and blood gas results and SF-36 questionnaire results in IPF patients qualified for lung transplantation. There was a positive correlation between the partial pressure of oxygen (PaO(2)), on one side, and mental and general health, on the other. There also were positive correlations between FEV1 and SF and FEV1 and the level of bodily pain (BP). We conclude that the SF-36 questionnaire is a sensitive tool to assess the quality of life in IPF patients qualified for lung transplantation. The information gained can help assess the severity of the disease, clinical symptoms, and functional impairment in these patients.

Entities:  

Mesh:

Year:  2005        PMID: 16204782

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  9 in total

Review 1.  Preoperative physiotherapy in subjects with idiopathic pulmonary fibrosis qualified for lung transplantation: implications on hospital length of stay and clinical outcomes.

Authors:  Massimiliano Polastri; Andrea Dell'Amore; Giulia Zagnoni; Stefano Nava
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

2.  Impact of a disease-management program on symptom burden and health-related quality of life in patients with idiopathic pulmonary fibrosis and their care partners.

Authors:  Kathleen Oare Lindell; Ellen Olshansky; Mi-Kyung Song; Thomas G Zullo; Kevin F Gibson; Naftali Kaminski; Leslie A Hoffman
Journal:  Heart Lung       Date:  2009-11-20       Impact factor: 2.210

3.  Dyspnea and quality of life in patients referred for lung transplantation.

Authors:  W Lutogniewska; D Jastrzebski; J Wyrwol; B Ksiazek; M Ochman; K Kowalski; A Margas; P Kubicki; J Kozielski
Journal:  Eur J Med Res       Date:  2010-11-04       Impact factor: 2.175

4.  The effects of indwelling voice prosthesis on the quality of life, depressive symptoms, and self-esteem in patients with total laryngectomy.

Authors:  Beldan Polat; Kadir Serkan Orhan; Mustafa Caner Kesimli; Yasemin Gorgulu; Murat Ulusan; Kemal Deger
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-19       Impact factor: 2.503

5.  The Burden of Illness of Idiopathic Pulmonary Fibrosis: A Comprehensive Evidence Review.

Authors:  Alex Diamantopoulos; Emily Wright; Katerina Vlahopoulou; Laura Cornic; Nils Schoof; Toby M Maher
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

6.  Quality of life and its effective factors in tuberculosis patients receiving directly observed treatment short-course (DOTS).

Authors:  Shahriar Salehitali; Kobra Noorian; Masoud Hafizi; Ali Hassanpour Dehkordi
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2019-02-08

7.  A functional assessment of patients two years after lung transplantation in Poland.

Authors:  Dariusz T Jastrzębski; Anna Gumola; Jacek Wojarski; Sławomir Żegleń; Marek Ochman; Damian Czyżewski; Dariusz Ziora; Marian Zembala; Jerzy Kozielski
Journal:  Kardiochir Torakochirurgia Pol       Date:  2014-06-29

8.  Computational Modeling Predicts Simultaneous Targeting of Fibroblasts and Epithelial Cells Is Necessary for Treatment of Pulmonary Fibrosis.

Authors:  Hayley C Warsinske; Amanda K Wheaton; Kevin K Kim; Jennifer J Linderman; Bethany B Moore; Denise E Kirschner
Journal:  Front Pharmacol       Date:  2016-06-23       Impact factor: 5.810

9.  Pulmonary Rehabilitation with a Stabilometric Platform after Thoracic Surgery: A Preliminary Report.

Authors:  Dariusz Jastrzębski; Aleksandra Żebrowska; Sebastian Rutkowski; Anna Rutkowska; Joanna Warzecha; Bettina Ziaja; Aleksandra Pałka; Barbara Czyżewska; Damian Czyżewski; Dariusz Ziora
Journal:  J Hum Kinet       Date:  2018-12-31       Impact factor: 2.193

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.